Muzaffer Deǧertekin

3.8k total citations
77 papers, 2.5k citations indexed

About

Muzaffer Deǧertekin is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Muzaffer Deǧertekin has authored 77 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 51 papers in Surgery and 29 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Muzaffer Deǧertekin's work include Coronary Interventions and Diagnostics (37 papers), Cardiac Valve Diseases and Treatments (30 papers) and Cardiac Imaging and Diagnostics (26 papers). Muzaffer Deǧertekin is often cited by papers focused on Coronary Interventions and Diagnostics (37 papers), Cardiac Valve Diseases and Treatments (30 papers) and Cardiac Imaging and Diagnostics (26 papers). Muzaffer Deǧertekin collaborates with scholars based in Türkiye, Netherlands and United States. Muzaffer Deǧertekin's co-authors include Patrick W. Serruys, Kengo Tanabe, Pim de Feyter, Pieter C. Smits, Willem J. van der Giessen, Evelyn Regar, Jürgen Ligthart, Ron T. van Domburg, Pedro A. Lemos and Francesco Saia and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Muzaffer Deǧertekin

70 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muzaffer Deǧertekin Türkiye 26 2.0k 1.5k 1.0k 700 133 77 2.5k
Pim de Feyter Netherlands 35 3.3k 1.6× 2.6k 1.7× 2.1k 2.0× 1.1k 1.5× 349 2.6× 101 4.0k
Kengo Tanabe Japan 36 4.2k 2.1× 3.0k 2.0× 1.9k 1.9× 1.4k 2.1× 74 0.6× 124 4.7k
Bernardo Cortese Italy 27 2.3k 1.1× 1.7k 1.1× 940 0.9× 1.1k 1.5× 85 0.6× 229 2.9k
W. Rutishauser Switzerland 31 1.5k 0.7× 1.5k 1.0× 1.4k 1.4× 502 0.7× 82 0.6× 135 2.5k
Taishi Yonetsu Japan 32 3.0k 1.5× 1.9k 1.3× 2.3k 2.3× 1.2k 1.7× 115 0.9× 239 3.9k
Ken Kozuma Japan 36 3.8k 1.9× 3.2k 2.1× 1.8k 1.8× 1.4k 2.0× 337 2.5× 261 5.0k
Roberto Diletti Netherlands 31 2.3k 1.1× 1.8k 1.2× 1.2k 1.2× 788 1.1× 108 0.8× 177 2.7k
Amish N. Raval United States 22 777 0.4× 901 0.6× 519 0.5× 472 0.7× 263 2.0× 89 2.1k
Eun‐Ah Park South Korea 26 600 0.3× 950 0.6× 983 1.0× 697 1.0× 439 3.3× 154 2.3k
Kelly Schlendorf United States 17 2.4k 1.2× 685 0.4× 1.1k 1.1× 884 1.3× 186 1.4× 89 3.1k

Countries citing papers authored by Muzaffer Deǧertekin

Since Specialization
Citations

This map shows the geographic impact of Muzaffer Deǧertekin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muzaffer Deǧertekin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muzaffer Deǧertekin more than expected).

Fields of papers citing papers by Muzaffer Deǧertekin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muzaffer Deǧertekin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muzaffer Deǧertekin. The network helps show where Muzaffer Deǧertekin may publish in the future.

Co-authorship network of co-authors of Muzaffer Deǧertekin

This figure shows the co-authorship network connecting the top 25 collaborators of Muzaffer Deǧertekin. A scholar is included among the top collaborators of Muzaffer Deǧertekin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muzaffer Deǧertekin. Muzaffer Deǧertekin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yıldırımtürk, Özlem, et al.. (2025). A Diagnostic Paradigm Shift in Acute Myocardial Infarction. JACC Advances. 4(11). 102227–102227. 2 indexed citations
2.
Çavuşoğlu, Yüksel, Omaç Tüfekçioğlu, Ebru Özpelit, et al.. (2024). Current barriers and recommendations on the diagnosis of transthyretin amyloid cardiomyopathy: a Delphi study. Frontiers in Cardiovascular Medicine. 11. 1299261–1299261. 1 indexed citations
3.
4.
Yılmaz, Seda Güleç, et al.. (2021). Investigation of Circulating miRNA-133, miRNA-26, and miRNA-378 as Candidate Biomarkers for Left Ventricular Hypertrophy. In Vivo. 35(3). 1605–1610. 6 indexed citations
5.
Ünal, Gözde, et al.. (2012). An automatic branch and stenoses detection in computed tomography angiography. 582–585. 1 indexed citations
6.
Kahvecı, Gökhan, Fatih Bayrak, Bülent Mutlu, et al.. (2007). Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Active Infective Endocarditis. The American Journal of Cardiology. 99(10). 1429–1433. 49 indexed citations
7.
Arampatzis, Chourmouzios A., Angela Hoye, Pedro A. Lemos, et al.. (2004). Elective sirolimus‐eluting stent implantation for multivessel disease involving significant LAD stenosis: One‐year clinical outcomes of 99 consecutive patients—the Rotterdam experience. Catheterization and Cardiovascular Interventions. 63(1). 57–60. 14 indexed citations
8.
Lemos, Pedro A., Chourmouzios A. Arampatzis, Francesco Saia, et al.. (2004). Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry). The American Journal of Cardiology. 93(5). 633–636. 39 indexed citations
9.
Saia, Francesco, Pedro A. Lemos, Georgios Sianos, et al.. (2003). Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy. The American Journal of Cardiology. 92(2). 200–203. 36 indexed citations
10.
Lemos, Pedro A., Chi‐Hang Lee, Muzaffer Deǧertekin, et al.. (2003). Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes. Journal of the American College of Cardiology. 41(11). 2093–2099. 110 indexed citations
11.
Saia, Francesco, Pedro A. Lemos, Muzaffer Deǧertekin, et al.. (2003). Sirolimus-eluting stents for treatment of in-stent restenosis in the real world: Preliminary results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Journal of the American College of Cardiology. 41(6). 53–53. 3 indexed citations
12.
Lemos, Pedro A., Paul Cummins, Chi‐Hang Lee, et al.. (2003). Usefulness of percutaneous left ventricular assistance to support high-risk percutaneous coronary interventions. The American Journal of Cardiology. 91(4). 479–481. 25 indexed citations
13.
Deǧertekin, Muzaffer, Evelyn Regar, Kengo Tanabe, et al.. (2003). Sirolimus-eluting stent for treatment of complex in-stent restenosis. Journal of the American College of Cardiology. 41(2). 184–189. 162 indexed citations
14.
Gijsen, Frank, Jolanda J. Wentzel, Johan C.H. Schuurbiers, et al.. (2003). Usefulness of shear stress pattern in predicting neointima distribution in sirolimus-eluting stents in coronary arteries. The American Journal of Cardiology. 92(11). 1325–1328. 68 indexed citations
15.
Tanabe, Kengo, Pedro A. Lemos, Chi‐Hang Lee, et al.. (2003). The impact of sirolimus-eluting stents on the outcome of patients with bifurcation lesions. Journal of the American College of Cardiology. 41(6). 12–13. 6 indexed citations
16.
Sönmez, Kenan, Ahmet Akçay, Mustafa Akçakoyun, et al.. (2002). [Distribution of therapeutic procedures and choice of drug therapies in patients with angiographically confirmed coronary artery disease].. PubMed. 2(1). 18–23, AXVI. 1 indexed citations
17.
Deǧertekin, Muzaffer, E. Regar, J. Eduardo Sousa, et al.. (2002). Incidence of incomplete stent apposition at six month follow-up in the multi center RAVEL trial. Journal of the American College of Cardiology. 39. 38–38. 7 indexed citations
18.
Serruys, Patrick W., Alexandre Abizaid, David A. Foley, et al.. (2002). Sirolimus-eluting stents abolish neointimal hyperplasia in patients with in-stent restenosis: late angiographic and intravascular ultrasound results. Journal of the American College of Cardiology. 39. 37–37. 4 indexed citations
19.
Tanabe, Kengo, Patrick W. Serruys, Muzaffer Deǧertekin, et al.. (2002). Fate of side branches after coronary arterial sirolimus-eluting stent implantation. The American Journal of Cardiology. 90(9). 937–941. 37 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pim de Feyter Breakdown of academic impact, for papers by Kengo Tanabe Breakdown of academic impact, for papers by Bernardo Cortese Breakdown of academic impact, for papers by W. Rutishauser Breakdown of academic impact, for papers by Taishi Yonetsu Breakdown of academic impact, for papers by Ken Kozuma Breakdown of academic impact, for papers by Roberto Diletti Breakdown of academic impact, for papers by Amish N. Raval Breakdown of academic impact, for papers by Eun‐Ah Park Breakdown of academic impact, for papers by Kelly Schlendorf
Rankless by CCL
2026